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Abstract 
Back ground: Subclinical hypothyroidism (SH) is defined by an elevated serum thyrotropin level and normal 
serum thyroxine concentration. While strong evidence clearly demonstrates that overt dysfunctions (hyper- or 
hypothyroidism) have deleterious effects on pregnancy outcome, subclinical disease, namely subclinical 
hypothyroidism, has still to be conclusively defined as a risk factor for adverse outcomes., of those bad obstetric 
outcomes, placental abruption (PA) (accidental hemorrhage) is associated with underlying risk factors both 
jeopardizing trophoblast and vascular function. Subclinical hypothyroidism may relate to both conditions.   Aim 
of study: to prove the association between subclinical hypothyroidism and placental abruption(accidental 
hemorrhage)  in study group compared to  control group. 
Setting:  a prospective case controlled study involves total 109 laboring women, who attended Al-Zahra teaching 
hospital at Annajaf city-Iraq between  March to September 2013.  
Patients and methods:of total 109 women entered our study, 54 with normal labour and were regarded as control 
group and 55 with clinical diagnosis of placental abruption, after complete history and examination, blood 
sample withdrawn and thyroid function test, TSH, T3, T4, and free T4 were measured  using commercially 
available Minividas kits (biomerieux, France), Minividas was performed according to manufacturer instructions. 
The normal value for T3 was (0.95-2.23), T4 (60-120) and TSH (0.25-5) µIU/ml and freeT4 (0.76-2.24). Those 
who had high TSH and low T3, T4 and free T4 when compared to laboratory specific normal values, were 
diagnosed as clinical (overt) hypothyroidism, and were excluded from our study.  those who had high TSH but 
normal freeT4 thyroid hormone were diagnosed to have  subclinical hypothyroidism, those in whom all hormone 
values were within  normal limits were designated as euthyroid. Statistical analysis: These were used to accept 
or reject the statistical hypotheses, they include the followings: ANOVA test (F-test) and (chi square test). The 
comparison of significant (P-value) in any test were S= Significant difference (P≤ 0.05). Results: 
Of total 109 participants 54 regarded as control while 55 were diagnosed clinically as cases of PA, there were no 
statistical significant difference between two groups in maternal age with mean maternal age of 27.92±5.42 SD 
and 27.49±6.58 SD for control and PA respectively,  low parity dominated the picture for both groups and 
although the ratio of those who were P0-P2 was higher in cases of PA 92.7% compared to control group 
87.7%this did not reach statistical significance with P value of 0.09, most of our participants were urban and 
there were no statistical clinical significance between two groups with figures of 76.3% and 79.6% for PA and 
control groups respectively, but there was statistically significance difference in gestational age between our 
study groups with PA tends to occur at smaller gestational age 34.67 weeks±3.39 SD compared to control group 
37.57 weeks±1.57 SD, surprisingly  there was nearly fourfold rise in incidence of SH in patients with PA 
compared to control group with ratio of 16.3% and 3.7% for PA and control group respectively. And again there 
was no statistical significance in identification of SH for those who were term or preterm  in PA group (17.6% vs 
15.1%).    
Discussion:  subclinical hypothyroidism was identified in 3.7% of the control  population tested, and this 
corresponds with all previous reports 2% to 5% in pregnant women. however, this ratio increased to 16.3%, 9/55 
(nearly fourfold ) of cases diagnosed with clinical abruption a figure which was higher than reviewed  in 
previous reports of 2-3 fold rise incidence of placental abruption with subclinical hypothyroidism. This  results 
agree with  Casey and colleagues who  studied pregnancy complications with SH, who found that Significantly 
more placental abruptions (relative risk [RR], 3.0; 95% CI, 1.1-8.2), were found in the SH group, but disagree 
with Cleary-Goldman and colleagues who reported  on First and Second Trimester Evaluation of Risk 
(FASTER) trial, in which the researchers found no increased risk of placental abruption. Unlike Brian M. Casey, 
who found that  women with subclinical hypothyroidism were significantly older than control women3, in this 
study  there was no statistically significant difference in mean  maternal age between two  groups, there were 
also no significant differences in other demographic variables like residency and parity,however;  gestational age 
(GA) was significantly lower for cases PA,  but when gestational age  studied  in relation to placental abruption 
with SH at term and preterm gestational ages 3/17 vs 6/38 respectively, this failed  to reach statistical 
significance. 
Conclusion: 
1-SH is not uncommon condition among our laboring population  
2-SH was found to increase fourfold risk of placental abruption in this study  
3-maternal age, parity, residence all were insignificant confounders between control and PA group 
4- placental abruption tends to occur at preterm gestational age but this failed to reach statistical significance for 
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cases with SH in term and preterm GA. 
Introduction 
subclinical hypothyroidism and placental abruption 
in spite of the overwhelming efforts offered by Iraqi ministry of health  in facing health challenges  and the 
remarkable improvement in health services overall , our country is still lacking an organized and effective 
screening for number of diseases that can adversely affect maternal and perinatal outcome, and indeed still a lot 
of pregnancies are lost at various stages of pregnancy, labour, early and late neonatal period without knowing the 
exact cause for such bad outcomes. And one of these important health issues that requires strict guidelines 
adherence is thyroid dysfunction.    
Thyroid disorders are among the most common endocrinopathies encountered during pregnancy. 
Hyperthyroidism accounting for approximately 0.5% to 1% and hypothyroidism for 2.5% to 3%1 . 
Hypothyroidism is even more common in the setting of iodine deficiency approaching in one study as high 
prevalence as 6.3% in developing country, India2. Clinical thyroid dysfunction has been associated with 
pregnancy complications such as hypertension, preterm birth, low birth weight, placental abruption, and fetal 
death. The relationship between subclinical hypothyroidism and pregnancy outcomes has not been well 
studied.3,4 
The term subclinical denotes the presence of a disease without obvious symptoms, which means that evolution of 
the disease might be at an early stage. subclinical hypothyroidism is defined as an elevated serum thyroid 
stimulating hormone (TSH) level  and a serum free thyroxine (FT4) level that is within the normal laboratory and 
trimester-specific reference ranges. 1,5In fact thyroid changes it's physiology during pregnancy and analysis of 
thyroid function tests (TFT) requires thorough understanding of these physiological changes prior interpretation. 
The gland as whole increases in size and becomes more vascular, beta chorionic gonadotrophin (HCG) causes 
thyroid stimulation since 1st trimester due to structural analogy with thyroid stimulating hormone (TSH)6. The 
thyrotrophic activity of HCG causes also a decrease in TSH concentration so that pregnant women have lower 
serum TSH concentration than non pregnant women, the circulating level of thyroid binding globulin TBG are 
also increased by estrogen stimulation on the other hand the increased renal clearance, fetal intake and placental 
metabolism induce a relative decline in iodide bioavailability7. Total concentration of triiodothyronin (T3) and 
thyroxin(T4) increase in early pregnancy and achieve plateau early in 2nd trimester reaching a concentration 
value 30-100% greater than prepregnancy, primarily following the rise in TBG8. Some authors have reported a 
decrease in free T3 and T4 concentrations, whereas reported no change or even increase, therefore; changes in 
free hormones are controversial, though pregnant women have lower free hormones concentrations at term than 
non pregnant women. 9   
 
Fig. 1. The pattern of changes in serum concentrations of thyroid function studies and hCG according to 
gestational age. The shaded area represents the normal range of thyroid-binding globulin, total thyroxine, 
thyroid-stimulating hormone or free T4 in the nonpregnant woman.TBG, thyroid-binding globulin; T4, 
thyroxine; TSH, thyroid-stimulating hormone. Modified from Brent GA. Maternal thyroid function: 
interpretation of thyroid function6. Maternal thyroxine is particularly critical early in pregnancy because the fetal 
thyroid gland cannot synthesize iodothyronines until after 10 weeks of gestation. From this time onward, 
maternal as well as fetal thyroid hormones seem to be necessary for normal neurodevelopment.10 It was reported 
that children of women whose TSH levels were elevated during the midtrimester of pregnancy had a slight but 
significant reduction in intelligence quotient ( IQ) scores between 7 and 9 years of age when compared with 
infants of euthyroid women10. Women with TSH values more than 10 mU/L also had significantly more stillborn 
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infants. Somewhat related are previous reports that subclinical maternal hypothyroidism might be associated 
with poor pregnancy outcomes such as placental abruption, preterm birth, and low birth weight infants.11,12 
The table below shows causes of subclinical hypothyroidism and differentiation from other causes of increases in 
serum TSH concentrations 
Causes of persistent subclinical hypothyroidism 
• Chronic autoimmune thyroiditis 
• Partial thyroidectomy 
• Radioactive iodine therapy for treatment of hyperthyroidism 
• External radiotherapy of the head and neck in patients with Hodgkin’s lymphoma, 
leukaemia, aplastic anaemia, brain tumours, or bone-marrow transplantation 
• Infi ltrative disorders of the thyroid gland (eg, amyloidosis, sarcoidosis, 
haemochromatosis, or Riedel’s thyroiditis) 
• Persistent TSH increase after an episode of subacute thyroiditis, post-partum 
thyroiditis, or painless thyroiditis 
• Drugs impairing thyroid function in patients with autoimmune thyroiditis (iodine and 
iodine-containing drugs, such as amiodarone and radiographic contrast agents, 
lithium carbonate, cytokines [especially interferon alfa], or kinase inhibitors) 
• Inadequate replacement therapy for overt hypothyroidism because of one of the 
following reasons: inadequate dose; increased need for levothyroxine (increased body 
weight and pregnancy); non-compliance; drug interactions (ferrous sulfate, calcium 
carbonate, colestyramine, sucralphate, orlistat, possibly dietary soy and fibre, proton pump 
inhibitors, aluminum hydroxide, ion exchange resins, raloxifene, or oestrogens); 
increased T4 clearance (phenytoin, carbamazepine, or phenobarbital); malabsorption 
(eg, Helicobacter pylori infection, coeliac disease, or atrophic gastritis); or toxic 
substances, industrial, and environmental agents (eg, polychlorinated biphenyls) 
• Thyroid dysgenesis 
• Iodine defi ciency 
Causes of physiological or transient increases in serum TSH concentrations 
• Diurnal variation with a nocturnal surge and highest values early in the morning 
• Recovery phase from non-thyroidal illness 
• After withdrawal of thyroid hormone therapy in patients in euthyroid state 
• Transient subclinical hypothyroidism after subacute, painless, or post-partum thyroiditis 
Causes of increased serum TSH concentrations that are not subclinical 
hypothyroidism 
• Laboratory analytical problem (assay variability, abnormal TSH isoforms, or 
heterophilic antibodies) 
• Elderly patients with small increases in serum TSH concentrations 
• Obesity 
• TSH-secreting pituitary adenoma 
• Isolated pituitary resistance to thyroid hormone 
• TSH with reduced biological activity 
• Impaired renal function 
• Untreated adrenal insuffi ciency 
• Serum TSH concentration outside of the reference range but normal for that 
individual because the reference range only encompasses 95–97・5% of normal 
individuals 
TSH=thyroid-stimulating hormone. T4=thyroxine. 
Table.  1 causes of persistent SH, transient TSH elevation, and increased serum TSH concentrations that 
are not subclinical hypothyroidism13 
Of the bad obstetric outcomes associated with SH to be elucidated in our study  is placental abruption, and it is 
classically defined as complete or partial premature separation of a normally implanted placenta with 
hemorrhage into the decidua basalis14, Symptoms of abruption vary immensely from an asymptomatic form in 
which the diagnosis is made only on placental inspection at delivery to massive abruption leading to fetal death 
and severe maternal morbidity, and it is the most common cause of pathological vaginal bleeding in late 
pregnancy.15The bleeding of placental abruption typically insinuates itself between the membranes and uterus, 
ultimately escaping through the cervix, causing external hemorrhage (65-80%). Less often, the blood does not 
escape externally but is retained between the detached placenta and the uterus, leading to concealed 
hemorrhage(20-35%)16. The diagnosis of placental abruption is always clinical 17,14, and the condition should be 
suspected in women who present with vaginal bleeding or abdominal pain or both, a history of trauma, and in 
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those who present with otherwise unexplained preterm birth or bloody amniotic fluid14, although in most of the 
cases there is no identifiable underlying cause, many risk factors are blamed like   age, parity, race,  familial 
factors, hypertension, prematurely ruptured membranes and preterm delivery, smoking, cocaine abuse, 
thrombophilias, trauma, leiomyomas, previously scarred uterus, anemia/folate deficiency and recurrent 
abruption.18,15, 11 
it has been shown that individuals with subclinical hypothyroidism have impaired endothelium-derived 
vasodilatation from diminished nitric oxide secretion that is restored after thyroxine (T4) replacement19, there is 
further evidence of vascular-related sequelae. Specifically, autoimmune thyroid disorders have been associated 
with an increased risk for placental abruption.20We designed this study to further elucidated the association 
between placental abruption and SH. 
 
MATERIALS AND METHODS 
prospective case controlled study involves total 109 laboring women, who attended Al-Zahra teaching hospital at 
Annajaf city between  March to September 2013, 54 with normal labour and they were regarded as control group 
and 55 with clinical diagnosis of placental abruption (vaginal bleeding, uterine hypertonicity, blood stained 
liquor which were all later confirmed by presence of retroplacental clots after vaginal or caesarean birth ) and 
were regarded as study group. After being consented to participate our study,   All patients underwent a 
comprehensive medical evaluation with complete history. Maternal age, parity, gestational age, residence, past 
obstetric history of adverse pregnancy outcome(i. e. early pregnancy loss, placental abruption, preeclampsia, 
intrauterine growth restriction, intrauterine death) past medical history of thyroid disease or type 1 diabetes,  
thyroidectomy,  radioactive iodine therapy for treatment of hyperthyroidism,  external radiotherapy of the head  
and neck ,  physical examination, including general examination, vital signs, BMI, examination for clinical 
goiter, maternal and fetal condition assessed as well labour stage, blood sample withdrawn as for routine 
management of labour, placental abruption and thyroid function test, TSH, T3, T4 and free T4,  cases with overt 
thyroid dysfunction overt hyper/or hypo-thyroidism diagnosed by history and abnormal thyroid function test 
were excluded from our study.It was made sure that being involved in this study did not delay the urgent 
management of accidental hemorrhage, as withdrawing blood samples was done routinely for all cases with 
normal labour and for those with abruption for baseline assessment of haematocrit, renal function, and 
coagulation profile added to our study investigation for thyroid function, no known serious consequences of 
blood sampling, but discomfort, bruising and bleeding were all minor complications.  Five ml of blood obtained 
by venepuncture,  dispensed in to a plain tube, and left for 15 minutes at 4C to clot. Then, it was centrifuged at 
3000 rpm for 10 minutes to collect serum. Thyroid function test (T3, T4, free T4 and TSH) were determined 
using commercially available Minividas kits (biomerieux, France), Minividas was performed according to 
manufacturer instructions. The normal value for T3 was (0.95-2.23), T4 (60-120) and TSH (0.25-5) µIU/ml and 
freeT4 (0.76-2.24 ). Those who had high TSH and low T3&/T4 when compared to laboratory specific normal 
values, were diagnosed as clinical (overt) hypothyroidism, those who had high TSH but normal freeT4 thyroid 
hormone were diagnosed to have  subclinical hypothyroidism (SH), those in whom all hormone values were 
within  normal limits were designated as euthyroid.  
Statistical analysis: 
   These were used to accept or reject the statistical hypotheses, they include the followings: ANOVA test (F-
test) and (chi square test). The comparison of significant (P-value) in any test were S= Significant difference (P≤ 
0.05). NS=Non Significant difference (P>0.05). All the statistical analysis was done by using Pentium-4 
computer through the SPSS program     (version-14). 
Results:  
Figure1: illustrates the number of subclinical hypothyroidism(SH) in both control and placental abruption 
groups. 
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▪mean TSH for cases diagnosed with SH is  5.38±0.72, mean free T4 1.75±0.33 
Table (1): Number of patients found to have subclinical hypothyroidism in both control and placental abruption 
groups. 
P – value  control abruption Group 
P – value = 0.05 
chi square =3.844 
2(3.70) 9(16.3) Subclinical hypothyroidism 
52 46 Euthyroid  
54 55 Total  
 
Table (2): Mean of maternal age ±standard deviation for both control and placental abruption groups 
Group NO. Mean Std. Deviation F-Test P-Value 
Placental abruption 55 27.49 6.58 0.141 0.708 
Control 54 27.92 5.42 
Total 109 27.70 6.01 
 
Table ( 3 ): parity of women in both control and PA groups. 
Group NO. 0-2 3≥ Chi square Test P-Value 
Placental abruption 55 51 4 7.834 0.09 
Control 54 47 7 
Total 109 98 11 
 
Table  (4 ) residence of women in both control and PA. 
Group NO. Urban  Rural  Chi square Test P-Value 
Placental abruption 55 42 13 0.169 0.681 
Control 54 43 11 
Total 109 85 24 
 
Table (5): mean gestational age in cases of placental abruption compared to control group 
Group NO. Mean Std. Deviation F-Test P-Value 
Placental abruption 55 34.67 3.39 32.579 0.001 
Control 54 37.57 1.57 
Total 109 36.11 3.01 
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Figure (2): Maternal age distribution for both cases of placental abruption and control, the difference does not 
reach statistical significance. 
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Figure (3):There is statistically significant younger gestational age for placental abruption cases than control 
group. 
M
e
a
n
 
o
f G
e
s
ta
tio
n
 
A
ge
38.00
37.50
37.00
36.50
36.00
35.50
35.00
group
Control
34.50
Placental abruption
 
Table(6): number of cases of PA affected by SH at term and preterm gestational age. 
P – value  Abruption at preterm (GA) Abruption  at term  Group of placental abruption 
P – value = 0.663 
chi square = 0.190 
6(15.78%) 3(17.6%) Subclinical hypothyroidism 
33 14 Euthyroid  
38 17 Total  
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Discussion 
Thyroid dysfunction is the most common endocrinological disorder affecting women of child-bearing age,  and 
typically manifests during reproductive years, with more than half of those cases being undiagnosed. While both 
thyroid dysfunctions are important, the state of hypothyroidism is considered to be the more serious regarding 
pregnancy21. 
The important finding in this prospective  cross-sectional case controlled study are first:  subclinical 
hypothyroidism was identified in 3.7% of the control  population tested, and this 
corresponds with virtually all previous reports of subclinical hypothyroidism has a prevalence of 2% to 
5% in pregnant women.3,22, 23,24,however, this ratio increased to 16.3%, 9/55 (nearly fourfold ) of cases 
diagnosed with clinical abruption as it was explained in table (1),  a figure which was statistically significant and 
even higher than reviewed in  previous reports with stated association of 2-3 fold rise incidence of placental 
abruption with subclinical hypothyroidism. 25, 26, 3  
Casey and colleagues studied pregnancy complications with SH, Subjects who met SH criteria were 
(2.3%) Their pregnancy outcomes were compared with those of control subjects with a TSH in normal ranges, 
researchers found no differences in gestational hypertension, preeclampsia, birth weight, or in fetal or neonatal 
death. Significantly more placental abruptions (relative risk [RR], 3.0; 95% CI, 1.1-8.2), were found in the SH 
group.3Cleary- 
Goldman and colleagues reported on a series of subjects who were a subset of the First and Second 
Trimester Evaluation of Risk (FASTER) trial, in this trial,  the researchers found no increased risk of placental 
abruption, and other adverse pregnancy outcomes. 27 
It is unclear why this large retrospective screening study reported such different conclusion. 
the mechanism of disease whereby thyroid hormone deficiency leads to placental abruption, and other 
pregnancy complications is not known. One unifying hypothesis is that thyroid hormone is necessary for normal 
placental development. Specifically, there is evidence that preterm delivery and vascular diseases such as 
preeclampsia and placental abruption may be causally linked to faulty early placentation.3 
 Unlike Brian M. Casey, who found that  women with subclinical hypothyroidism were significantly 
older than control women3, in our study  there was no statistically significant difference in mean  maternal age 
among those cases of placental abruption (27.49±6.58) and control group(27.92±5.42) as was shown in table( 2),  
Table (3) demonstrates that most of participant women were of low parity P0-2 were 98 out of total 
109 and there was no statistical difference in parity between control and PA groups( P= 0.09), this can be 
explained on cultural bases that most multiparous  women prefer home delivery by midwife rather than to be 
delivered at hospital, residence as well has no statistical significant differences in both control and PA group( P= 
0.681) and  majority of women 85 out of109 were urban as  shown in table (4 ), however; mean gestational age 
for cases of placental abruption in general was 34.67 and this was significantly lower than mean gestational age 
for control which was 37.57, but when gestational age  studied  in relation to placental abruption with SH as 
whown in table (6)  it was found that although 6 of38 (15.78%) cases of placental abruption who were affected 
by subclinical hypothyroidism were at preterm gestational age and ( 17.6%) of PA at term this did not reach 
statistical significance with P value of 0.663. 
 
Conclusion 
1-SH is not uncommon condition among our laboring population  
2-SH was found to increase fourfold risk of placental abruption in this study  
3-maternal age was insignificant confounder between control and PA group 
4- placental abruption tends to occur more frequently  at preterm gestational age but this failed to reach statistical 
significance for cases with SH between term and preterm. 
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